|
|
|
Insider
Information: |
Coughlin Christopher J |
Relationship: |
|
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
11 |
|
Direct
Shares |
343,051 |
|
Indirect Shares
|
17,342 |
|
|
Direct
Value |
$12,925,362 |
|
|
Indirect Value
|
$3,202,057 |
|
|
Total
Shares |
360,393 |
|
|
Total
Value |
$16,127,419 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-100.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Interpublic Group of Companies |
IPG |
CFO and COO, Director |
2004-05-18 |
81,842 |
2004-05-18 |
0 |
Premium* |
|
Dun & Bradstreet Corp |
DNB |
Director |
2017-03-10 |
16,535 |
2017-03-10 |
800 |
Premium* |
|
Johnson Controls International plc |
JCI |
EVP and CFO |
2010-11-26 |
88,558 |
2005-03-07 |
0 |
Premium* |
|
Covidien Plc |
COV |
Director |
2015-01-26 |
0 |
2015-01-26 |
0 |
Premium* |
|
Plx Pharma Inc |
PLXP |
Director |
2014-03-18 |
109,309 |
|
0 |
Premium* |
|
Allergan plc |
AGN |
Director |
2020-05-08 |
0 |
2020-05-08 |
16,542 |
Premium* |
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2021-07-21 |
0 |
2014-07-22 |
0 |
Premium* |
|
Hologic Inc |
HOLX |
Director |
2017-03-08 |
7,633 |
|
0 |
Premium* |
|
Prestige Brands Holdings Inc |
PBH |
Director |
2022-08-02 |
13,218 |
2019-07-30 |
0 |
Premium* |
|
Centene Corp |
CNC |
Director |
2024-06-30 |
25,956 |
2024-05-14 |
0 |
Premium* |
|
Karuna Therapeutics, Inc. |
KRTX |
|
2024-03-18 |
0 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
183 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KRTX |
Karuna Therapeutics, Inc. |
|
|
2023-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
990 |
990 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
|
|
2024-03-18 |
4 |
D |
$330.00 |
$326,700 |
D/D |
(990) |
0 |
0 |
- |
|
IPG |
Interpublic Group of Comp... |
CFO and COO |
|
2004-05-18 |
4 |
A |
$14.06 |
$749,989 |
D/D |
53,342 |
81,842 |
|
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2004-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
93 |
93 |
|
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2005-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
931 |
1,023 |
|
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2005-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
927 |
1,951 |
|
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2006-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
410 |
2,361 |
|
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2006-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
430 |
2,791 |
|
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2006-08-11 |
4 |
B |
$67.83 |
$40,862 |
I/I |
600 |
600 |
2.1 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2006-08-17 |
4 |
B |
$69.67 |
$6,967 |
I/I |
100 |
700 |
2.1 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2006-08-22 |
4 |
B |
$69.95 |
$6,995 |
I/I |
100 |
800 |
2.1 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2007-03-29 |
4 |
A |
$90.14 |
$698 |
D/D |
8 |
2,799 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2007-05-02 |
4 |
A |
$90.91 |
$29,909 |
D/D |
329 |
3,128 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2007-06-15 |
4 |
A |
$101.10 |
$782 |
D/D |
8 |
3,135 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2007-06-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
61,417 |
|
- |
|
COV |
Covidien Plc |
Director |
|
2007-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,090 |
63,507 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2007-07-02 |
4 |
A |
$103.63 |
$29,949 |
D/D |
289 |
3,424 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2007-07-02 |
4/A |
D |
$43.01 |
$282,328 |
D/D |
(6,565) |
56,942 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2007-09-17 |
4 |
A |
$98.15 |
$856 |
D/D |
9 |
3,433 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2007-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
8 |
56,950 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2007-12-14 |
4 |
A |
$91.08 |
$858 |
D/D |
9 |
3,442 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2008-01-02 |
4 |
D |
$43.65 |
$292,892 |
D/D |
(6,710) |
50,240 |
0 |
- |
|
COV |
Covidien Plc |
Director |
|
2008-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
8 |
50,248 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2008-03-03 |
4 |
A |
$86.22 |
$29,918 |
D/D |
347 |
3,789 |
0 |
- |
|
DNB |
Dun & Bradstreet Corp |
Director |
|
2008-03-17 |
4 |
A |
$80.38 |
$1,029 |
D/D |
13 |
3,802 |
0 |
- |
|
183 Records found
|
|
Page 1 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|